Key result
Autonomic modulation including ganglionated plexi ablation and risk factor correction shows promise for AF.
This review highlights the role of the autonomic nervous system in atrial fibrillation and discusses current and future translational therapeutic strategies including ablation, denervation, and lifestyle modifications.
Supports exploration of autonomic modulation for AF; leaves open whether these strategies improve outcomes in randomized settings.
The autonomic nervous system (ANS) is known to play an important role in the genesis and maintenance of atrial fibrillation (AF). Biomolecular and genetic mechanisms, anatomical knowledges with recent diagnostic techniques acquisitions, both invasive and non-invasive, have enabled greater therapeutic goals in patients affected by AF related to ANS imbalance. Catheter ablation of ganglionated plexi (GP) in the left and right atrium has been proposed in varied clinical conditions. Moreover interesting results arise from renal sympathetic denervation and vagal nerve stimulation. Despite all this, in the scenario of ANS modulation translational strategies we necessary must consider the treatment or correction of dynamic factors such as obesity, obstructive sleep apnea, lifestyle, food, and stress. Finally, new antiarrhythmic drugs, gene therapy and "ablatogenomic" could be represent exciting future therapeutic perspectives.
No takes yet. Share an insight, caveat, or question.
Rebecchi et al. (2021) conducted a review in Atrial fibrillation. Autonomic nervous system modulation was evaluated. Autonomic nervous system modulation, including ganglionated plexi ablation and correction of dynamic risk factors, represents a promising translational strategy for atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: